Search research articles
Contact Us
Filters
Showing results (161-170 of 176) with videos related to
Page
of 18
Sort By:
British Journal of Cancer
|
June 17, 2010
DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma
S Lee, N Syed, J Taylor, et al.
British Journal of Cancer
|
November 27, 2008
Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment
M J Slade, R Payne, S Riethdorf, et al.
Oncogene
|
June 10, 2014
KSR1 regulates BRCA1 degradation and inhibits breast cancer growth
J Stebbing, H Zhang, Y Xu, et al.
Oncogene
|
April 23, 2021
Correction to: KSR1 regulates BRCA1 degradation and inhibits breast cancer growth
J Stebbing, H Zhang, Y Xu, et al.
Cell Death & Disease
|
May 8, 2015
Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis
L Roca-Alonso, L Castellano, A Mills, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2021
Prevalence of ctDNA in early screen-detected breast cancers using highly sensitive and specific dual molecular barcoded personalised mutation assays
K Page, L J Martinson, R K Hastings, et al.
The Pharmacogenomics Journal
|
January 11, 2012
Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapy
A Pohl, A El-Khoueiry, D Yang, et al.
British Journal of Cancer
|
December 15, 2011
The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy
R E Payne, N L Hava, K Page, et al.
BMC Genomics
|
August 9, 2018
Gene editing in the context of an increasingly complex genome
K Blighe, L DeDionisio, K A Christie, et al.
The Pharmacogenomics Journal
|
October 8, 2014
Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancer
L Benhaim, W Zhang, T Wakatsuki, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 176) with videos related to
Sort By:
Page
of 18
British Journal of Cancer
|
June 17, 2010
DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma
S Lee, N Syed, J Taylor, et al.
British Journal of Cancer
|
November 27, 2008
Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment
M J Slade, R Payne, S Riethdorf, et al.
Oncogene
|
June 10, 2014
KSR1 regulates BRCA1 degradation and inhibits breast cancer growth
J Stebbing, H Zhang, Y Xu, et al.
Oncogene
|
April 23, 2021
Correction to: KSR1 regulates BRCA1 degradation and inhibits breast cancer growth
J Stebbing, H Zhang, Y Xu, et al.
Cell Death & Disease
|
May 8, 2015
Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis
L Roca-Alonso, L Castellano, A Mills, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2021
Prevalence of ctDNA in early screen-detected breast cancers using highly sensitive and specific dual molecular barcoded personalised mutation assays
K Page, L J Martinson, R K Hastings, et al.
The Pharmacogenomics Journal
|
January 11, 2012
Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapy
A Pohl, A El-Khoueiry, D Yang, et al.
British Journal of Cancer
|
December 15, 2011
The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy
R E Payne, N L Hava, K Page, et al.
BMC Genomics
|
August 9, 2018
Gene editing in the context of an increasingly complex genome
K Blighe, L DeDionisio, K A Christie, et al.
The Pharmacogenomics Journal
|
October 8, 2014
Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancer
L Benhaim, W Zhang, T Wakatsuki, et al.
Page
of 18